A G Iyevleva
Overview
Explore the profile of A G Iyevleva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
14
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aleksakhina S, Kramchaninov M, Mikushina A, Kubrina S, Petkau V, Ivantsov A, et al.
Clin Transl Oncol
. 2020 Sep;
23(4):874-881.
PMID: 32880048
Purpose: Endocrine therapy is a mainstay for the treatment of hormone receptor-positive breast cancer (BC); however, only a fraction of patients experience a pronounced response to antagonists of estrogen signaling....
2.
Bessonov A, Iyevleva A, Imyanitov E, Sokolenko A
Vopr Onkol
. 2019 Jan;
62(6):753-757.
PMID: 30695561
CHEK2 is classified as a moderate-penetrance gene for hereditary breast cancer (BC). In Russia, CHEK2 mutations hold second position in the list of BC-predisposing gene defects after BRCAl, and include...
3.
Yanus G, Akhapkina T, Ivantsov A, Preobrazhenskaya E, Aleksakhina S, Bizin I, et al.
Clin Genet
. 2018 Feb;
93(5):1015-1021.
PMID: 29406563
Distribution of cancer-predisposing mutations demonstrates significant interethnic variations. This study aimed to evaluate patterns of APC and MUTYH germ-line mutations in Russian patients with colorectal malignancies. APC gene defects were...
4.
Sokolenko A, Iyevleva A, Mitiushkina N, Suspitsin E, Preobrazhenskaya E, Kuligina E, et al.
Acta Naturae
. 2012 Jun;
2(4):31-5.
PMID: 22649661
Hereditary breast-ovarian cancer syndrome contributes to as much as 5-7% of breast cancer (BC) and 10-15% of ovarian cancer (OC) incidence. Mutations in the "canonical" genesBRCA1andBRCA2occur in 20-30% of affected...